methotrexate has been researched along with ANCA-Associated Vasculitides in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (2.70) | 29.6817 |
| 2010's | 29 (78.38) | 24.3611 |
| 2020's | 7 (18.92) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, YH; Song, GG | 1 |
| Cohen, P; Dion, J; Diot, E; Durel, CA; Grados, A; Guichard, I; Guillevin, L; Le Guern, V; Legendre, P; Limal, N; Mouthon, L; Régent, A; Samson, M; Sorin, B; Terrier, B | 1 |
| Hellmich, B; Mukhtyar, CB | 1 |
| Biedroń, G; Brzosko, I; Brzosko, M; Czuszyńska, Z; Dębska-Ślizień, A; Głuszko, P; Hawrot-Kawecka, A; Jakuszko, K; Jeleniewicz, R; Klinger, M; Kucharz, EJ; Kur-Zalewska, J; Madej, M; Majdan, M; Masiak, A; Musiał, J; Rowaiye, OO; Storoniak, H; Szczeklik, W; Sznajd, J; Tłustochowicz, W; Wawrzycka-Adamczyk, K; Wisłowska, M; Wójcik, K; Włudarczyk, A; Zdrojewski, Z | 1 |
| Scheicht, D | 1 |
| Miloslavsky, EM; Wallace, ZS | 1 |
| Cortazar, FB; Huizenga, NR; Laliberte, K; Niles, JL; Rhee, EP; Rosenthal, JM; Wallace, ZS; Zonozi, R | 1 |
| Benseler, SM; Cabral, DA; Charuvanij, S; Dancey, P; Eberhard, BA; Elder, ME; Foell, D; Hersh, AO; Huber, AM; Klein-Gitelman, M; Kostik, MM; Lawson, EF; Lee, T; Li, SC; Lubieniecka, JM; Luqmani, RA; Moorthy, LN; Morishita, KA; Nielsen, SM; Ristic, G; Shenoi, S; Toth, MB; Twilt, M; Yeung, RSM | 1 |
| Clowse, ME; Machen, L | 1 |
| Alberici, F; Andrulli, S; Buzio, C; Grasselli, C; Manenti, L; Maritati, F; Oliva, E; Palmisano, A; Pavone, L; Pesci, A; Santarsia, F; Santi, R; Tumiati, B; Urban, ML; Vaglio, A | 1 |
| Akikusa, J; Alsaleem, A; Chiang, GPK; Laxer, RM; Lee, JJY; Limenis, E; Sontichai, W; Yeung, RSM | 1 |
| Hoffman, GS | 1 |
| Mouthon, L | 1 |
| Bartsch, M; Effelsberg, NM; Hässler, F; Hentze, C; Miehle, N; Peter, HH; Salzer, U; Schlesier, M; Sic, H; Thiel, J; Venhoff, N; Voll, RE; Warnatz, K | 1 |
| Feldman, BM; Gross, WL; Guillevin, L; Hazlewood, GS; Metzler, C; Pagnoux, C; Tomlinson, GA | 1 |
| Nguyen, T; Vandergheynst, F | 1 |
| Bazsó, A; Kiss, E; Pálfi, P; Poór, G; Szabó, MZ | 1 |
| Fayad, A; González, G; Robaina Sindín, J; Smuclir Quevedo, A; Vazquez, V | 1 |
| Hoek, A; Sanders, JS; Stegeman, CA; Tuin, J; van Beek, AP | 1 |
| Carey, JJ; Coughlan, R; Donnellan, S; Garrahy, A; Giblin, L; Griffin, MD; Griffin, TP; Lappin, D; McNicholas, BA; Reddan, D; Ryan, L | 1 |
| Distler, O; Franzen, D; Jungraithmayr, W; Kolios, AG; Tzafos, S; Weder, W | 1 |
| Harper, L | 1 |
| Sharaf, PH; Yazici, Y | 1 |
| Erwig, LP; Savage, CO | 1 |
| Karjalainen, A; Pettersson, T | 1 |
| Chen, M; Kallenberg, CG | 1 |
| Belperio, JA; Lynch, JP; Wang, T; Weigt, SS | 1 |
| Dábague Guzmán, J; Pedroza Granados, J; Zúñiga Varga, J | 1 |
| Brunet, P; Burtey, S; Dussol, B; Seck, SM | 1 |
| de Groot, K; Faurschou, M; Flossmann, O; Höglund, P; Jayne, DR; Rasmussen, N; Westman, K | 1 |
| Martín-Suñé, N; Ríos-Blanco, JJ | 1 |
| Geetha, D; Seo, P | 1 |
| Luqmani, R | 1 |
| Hoffman, GS; Langford, CA | 1 |
| de Groot, K; Faurschou, M; Flossmann, O; Höglund, P; Jayne, D; Rasmussen, N; Westman, K | 1 |
| Jayne, D | 1 |
| Brachemi, S; Déziel, C; Goupil, R; Lavergne, V; Nadeau-Fredette, AC; Troyanov, S; Troyanov, Y | 1 |
18 review(s) available for methotrexate and ANCA-Associated Vasculitides
| Article | Year |
|---|---|
Comparative efficacy and safety of rituximab, mycophenolate, methotrexate, and cyclophosphamide versus azathioprine as maintenance therapy in antineutrophil cytoplasmic antibody-associated vasculitis: A Bayesian network meta-analysis of randomized control
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Methotrexate; Network Meta-Analysis; Randomized Controlled Trials as Topic; Remission Induction; Rituximab; Treatment Outcome | 2022 |
Management of ANCA associated vasculitis.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Cyclophosphamide; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Remission Induction; Rituximab | 2020 |
Vasculitis and Pregnancy.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Behcet Syndrome; Contraindications; Cyclophosphamide; Deprescriptions; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Pregnancy; Pregnancy Complications; Takayasu Arteritis; Tumor Necrosis Factor-alpha; Vasculitis | 2017 |
Hallmark trials in ANCA-associated vasculitis (AAV) for the pediatric rheumatologist.
Topics: Adult; Anti-Inflammatory Agents; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Child; Churg-Strauss Syndrome; Cyclophosphamide; Drug Substitution; Drug Therapy, Combination; Forecasting; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Leflunomide; Methotrexate; Mycophenolic Acid; Plasma Exchange; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Rituximab; Severity of Illness Index | 2019 |
L52. Vasculitis treatment: is it time to change the standard of care for ANCA-associated vasculitis?
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cooperative Behavior; Cyclophosphamide; Drug Therapy, Combination; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Interdisciplinary Communication; Methotrexate; Mycophenolic Acid; Randomized Controlled Trials as Topic; Remission Induction; Rituximab; Secondary Prevention; Standard of Care; Treatment Outcome | 2013 |
L44. Management of relapses in vasculitis.
Topics: Anti-Inflammatory Agents; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Combined Modality Therapy; Cyclophosphamide; Drug Therapy, Combination; Glucocorticoids; Humans; Immunization, Passive; Immunosuppressive Agents; Methotrexate; Plasma Exchange; Prognosis; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Rituximab; Tumor Necrosis Factor-alpha | 2013 |
Non-biologic remission maintenance therapy in adult patients with ANCA-associated vasculitis: a systematic review and network meta-analysis.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Randomized Controlled Trials as Topic; Remission Induction; Treatment Outcome | 2014 |
[Recent advances in the treatment of antineutrophil cytoplasm antibody associated vasculitides].
Topics: Algorithms; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Clinical Trials as Topic; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Kidney Transplantation; Methotrexate; Microscopic Polyangiitis; Mycophenolic Acid; Plasmapheresis; Prognosis; Rituximab; Severity of Illness Index; Terminology as Topic | 2015 |
Recent advances to achieve remission induction in antineutrophil cytoplasmic antibody-associated vasculitis.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Clinical Protocols; Cyclophosphamide; Humans; Immunosuppressive Agents; Immunotherapy; Methotrexate; Rituximab; Treatment Outcome | 2010 |
Necrotizing vasculitis--a 2009 update.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Behcet Syndrome; Churg-Strauss Syndrome; Evidence-Based Medicine; Female; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Male; Methotrexate; Microscopic Polyangiitis; Necrosis; Randomized Controlled Trials as Topic; Treatment Outcome; Vasculitis | 2009 |
ANCA-associated vasculitides: advances in pathophysiology and treatment.
Topics: Animals; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Cyclophosphamide; Disease Models, Animal; Disease Progression; Humans; Immunoglobulin G; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid | 2010 |
[Diagnosis and management of small vessel vasculitides].
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Disease Progression; Glucocorticoids; Humans; Immunologic Factors; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Plasmapheresis; Rituximab; Vasculitis | 2010 |
ANCA-associated vasculitides--advances in pathogenesis and treatment.
Topics: Animals; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; Cyclophosphamide; Disease Models, Animal; Glucocorticoids; Humans; Methotrexate; Mice; Remission Induction; Rituximab | 2010 |
Immunosuppressive and cytotoxic therapy: pharmacology, toxicities, and monitoring.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Time Factors | 2011 |
[Maintainance treatment of anti-neutrophil cytoplasm associated antibodies (ANCA)].
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Early Diagnosis; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Induction Chemotherapy; Isoxazoles; Leflunomide; Maintenance Chemotherapy; Methotrexate; Randomized Controlled Trials as Topic; Rituximab; Severity of Illness Index; Trimethoprim, Sulfamethoxazole Drug Combination | 2011 |
Pulmonary affectation of vasculitis.
Topics: Adrenal Cortex Hormones; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; Combined Modality Therapy; Granuloma, Respiratory Tract; Granulomatosis with Polyangiitis; Hemorrhage; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lung; Lung Diseases; Methotrexate; Plasmapheresis; Rituximab; Tumor Necrosis Factor-alpha; Vasculitis | 2012 |
Advances in therapy for ANCA-associated vasculitis.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Cyclophosphamide; Glucocorticoids; Humans; Methotrexate; Plasma Exchange; Recurrence; Remission Induction; Rituximab | 2012 |
Maintenance of clinical remission in ANCA-associated vasculitis.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; Cyclophosphamide; Disease Management; Drug Therapy, Combination; Glucocorticoids; Humans; Methotrexate; Plasmapheresis; Remission Induction; Rituximab | 2013 |
2 trial(s) available for methotrexate and ANCA-Associated Vasculitides
| Article | Year |
|---|---|
Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
Topics: Adolescent; Adult; Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Churg-Strauss Syndrome; Cyclophosphamide; Female; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Male; Methotrexate; Microscopic Polyangiitis; Middle Aged; Patient Safety; Patient Selection; Peripheral Nervous System Diseases; Proteinuria; Random Allocation; Recurrence; Remission Induction; Survival Analysis; Treatment Outcome | 2017 |
Brief Report: long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
Topics: Adolescent; Adult; Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Cyclophosphamide; Disease Progression; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Remission Induction; Surveys and Questionnaires; Treatment Outcome | 2012 |
17 other study(ies) available for methotrexate and ANCA-Associated Vasculitides
| Article | Year |
|---|---|
Rituximab plus methotrexate combination as a salvage therapy in persistently active granulomatosis with polyangiitis.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Granulomatosis with Polyangiitis; Humans; Methotrexate; Remission Induction; Retrospective Studies; Rituximab; Salvage Therapy; Treatment Outcome | 2022 |
Response to: 'Error in the dosage of methotrexate in the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis' by Scheicht.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Edetic Acid; Humans; Methotrexate | 2022 |
Treatment and its side effects in ANCA-associated vasculitides - Study based on POLVAS registry data.
Topics: Adult; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Poland; Prognosis; Registries; Retrospective Studies; Rituximab; Survival Rate | 2020 |
Error in the dosage of Methotrexate in the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Edetic Acid; Humans; Immunosuppressive Agents; Methotrexate | 2022 |
Incidence, Clinical Features, and Outcomes of Late-Onset Neutropenia From Rituximab for Autoimmune Disease.
Topics: Adult; Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Asymptomatic Diseases; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Fever; Filgrastim; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Hematologic Agents; Humans; Immunologic Factors; Incidence; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Nephrosis, Lipoid; Neutropenia; Proportional Hazards Models; Recurrence; Retrospective Studies; Risk Factors; Rituximab; Sepsis | 2021 |
Early Outcomes in Children With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Child; Cohort Studies; Cyclophosphamide; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Diseases; Lung Diseases; Male; Methotrexate; Mycophenolic Acid; Prospective Studies; Recurrence; Registries; Remission Induction; Retrospective Studies; Rituximab | 2017 |
B cell homeostasis is disturbed by immunosuppressive therapies in patients with ANCA-associated vasculitides.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; Azathioprine; B-Lymphocyte Subsets; Cyclophosphamide; Female; Homeostasis; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Count; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Rituximab | 2013 |
Pachymeningitis and aortitis in a patient with antineutrophil cytoplasmic antibody-associated vasculitis.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Aorta; Aortitis; C-Reactive Protein; Cervical Vertebrae; Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Meningitis; Methotrexate; Middle Aged; Neck Pain; Positron-Emission Tomography; Shoulder Pain; Steroids | 2014 |
[Clinical practice guideline for ANCA-associated vasculitis with renal involvement].
Topics: Adult; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Antirheumatic Agents; Azathioprine; Child; Clinical Trials as Topic; Cyclophosphamide; Evidence-Based Medicine; Glucocorticoids; Humans; Induction Chemotherapy; Kidney Diseases; Maintenance Chemotherapy; Methotrexate; Organ Dysfunction Scores; Plasmapheresis; Recurrence; Severity of Illness Index | 2015 |
Brief Report: Menopause and Primary Ovarian Insufficiency in Women Treated for Antineutrophil Cytoplasmic Antibody-Associated Vasculitides.
Topics: Adult; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Case-Control Studies; Cohort Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Incidence; Maintenance Chemotherapy; Menopause; Methotrexate; Middle Aged; Mycophenolic Acid; Prednisolone; Primary Ovarian Insufficiency; Remission Induction; Retrospective Studies; Risk Factors; Rituximab; Young Adult | 2016 |
ANCA-associated vasculitis: a comparison of cases presenting to nephrology and rheumatology services.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; C-Reactive Protein; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Ireland; Male; Methotrexate; Middle Aged; Nephrology; Recurrence; Remission Induction; Retrospective Studies; Rheumatology; Treatment Outcome | 2016 |
Rapid Growth of Lung Nodules due to Combined Pulmonary Vasculitis, Silicoanthracosis, and Chondrocalcinosis.
Topics: Anthracosilicosis; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antirheumatic Agents; Arthritis; Chondrocalcinosis; Humans; Immunologic Factors; Lung; Male; Methotrexate; Middle Aged; Multiple Pulmonary Nodules; Rituximab; Thoracoscopy; Tomography, X-Ray Computed | 2016 |
Clinical features and outcomes of ANCA-associated renal vasculitis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Churg-Strauss Syndrome; Creatinine; Cyclophosphamide; Female; Glomerulonephritis; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Induction Chemotherapy; Maintenance Chemotherapy; Male; Methotrexate; Microscopic Polyangiitis; Middle Aged; Plasmapheresis; Recurrence; Remission Induction; Renal Dialysis; Retrospective Studies | 2012 |
Methotrexate remains a valuable option for remission induction of nonsevere antineutrophil cytoplasmic antibody-associated vasculitis: comment on the article by Faurschou et al.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Remission Induction | 2013 |
Reply: To PMID 22614882.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Remission Induction | 2013 |
Treating vasculitis with conventional immunosuppressive agents.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Cyclophosphamide; Glucocorticoids; Guanidines; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid | 2012 |
Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis.
Topics: Adult; Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Chi-Square Distribution; Communicable Diseases; Cyclophosphamide; Female; Hospitals, University; Humans; Immunocompromised Host; Immunosuppressive Agents; Kaplan-Meier Estimate; Linear Models; Lymphocyte Count; Lymphopenia; Male; Methotrexate; Methylprednisolone; Middle Aged; Multivariate Analysis; Neutropenia; Plasmapheresis; Quebec; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome | 2013 |